The functioning side of the pancreas: a review on insulinomas
- PMID: 31368049
- DOI: 10.1007/s40618-019-01091-w
The functioning side of the pancreas: a review on insulinomas
Abstract
Purpose: Insulinomas are a rare type of neuroendocrine tumors, originating in the pancreas, difficult to diagnose and to treat. Due to its rarity, insulinomas are a not well-known pathological entity; thus, the diagnostic process is frequently a medical challenge with many possible differential diagnoses. The diagnostic process varies between non-invasive procedures, such as the fasting test or imaging techniques, and invasive ones. Insulinomas are rarely malignant, but the glycemic imbalance correlated with this tumor can frequently alter the quality of life of the patients and the consequent hypoglycemia can be extremely dangerous. Moreover, insulinomas can be associated with different genetic syndromes, such as Multiple Endocrine Neoplasia 1, accompanied by other specific symptoms. There are many different treatment strategies, depending on the need to control symptoms or control diseases progression, the only curative one being surgery.
Methods and results: We reviewed the evidences present in the literature on insulinomas and reported its main clinical characteristics and management strategies.
Conclusion: The aim of this review of the literature is to present the current knowledge on insulinomas, exploring the main clinical characteristics, the diagnostic tools, and the therapeutic strategies.
Keywords: Functioning neuroendocrine tumors; Hypoglycemia; Insulinoma; Neuroendocrine tumors; Pancreas.
Similar articles
-
Approach to the Patient: Insulinoma.J Clin Endocrinol Metab. 2024 Mar 15;109(4):1109-1118. doi: 10.1210/clinem/dgad641. J Clin Endocrinol Metab. 2024. PMID: 37925662 Free PMC article.
-
Diagnosis and management of insulinoma.World J Gastroenterol. 2013 Feb 14;19(6):829-37. doi: 10.3748/wjg.v19.i6.829. World J Gastroenterol. 2013. PMID: 23430217 Free PMC article. Review.
-
Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4.Endocr Pathol. 2007 Summer;18(2):79-85. doi: 10.1007/s12022-007-0014-8. Endocr Pathol. 2007. PMID: 17916997
-
Interventional vs surgical procedures in localized/nonmetastatic insulinomas (ablation vs surgery).Endocr Relat Cancer. 2023 May 2;30(6):e220362. doi: 10.1530/ERC-22-0362. Print 2023 Jun 1. Endocr Relat Cancer. 2023. PMID: 36952635 Review.
-
Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.J Clin Endocrinol Metab. 2003 Nov;88(11):5353-60. doi: 10.1210/jc.2002-021895. J Clin Endocrinol Metab. 2003. PMID: 14602773
Cited by
-
Case Report: Hypoglycemia Due to Metastatic Insulinoma in Insulin-Dependent Type 2 Diabetes Successfully Treated With 177 Lu-DOTATATE.Front Endocrinol (Lausanne). 2022 May 24;13:906012. doi: 10.3389/fendo.2022.906012. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35685218 Free PMC article. Review.
-
ATP6AP2 is robustly expressed in pancreatic β cells and neuroendocrine tumors, and plays a role in maintaining cellular viability.Sci Rep. 2023 Jun 7;13(1):9260. doi: 10.1038/s41598-023-36265-3. Sci Rep. 2023. PMID: 37286698 Free PMC article.
-
Ectopic insulinoma: a systematic review.Rev Endocr Metab Disord. 2023 Dec;24(6):1135-1146. doi: 10.1007/s11154-023-09824-2. Epub 2023 Jul 12. Rev Endocr Metab Disord. 2023. PMID: 37434098
-
Malignant Insulinoma: Diagnostic Difficulties and Treatment Strategies in a Case of Persistent Hypoglycemia.Cureus. 2024 Nov 28;16(11):e74700. doi: 10.7759/cureus.74700. eCollection 2024 Nov. Cureus. 2024. PMID: 39735090 Free PMC article.
-
Diagnosis and management of benign secreting pancreatic insulinoma: What's new? 4 case report.Rare Tumors. 2025 Jan 8;17:20363613241313409. doi: 10.1177/20363613241313409. eCollection 2025. Rare Tumors. 2025. PMID: 39790868 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical